Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study

British Journal of Pharmacology
Holger LanghofDaniel Strech

Abstract

Therapeutic area guidelines (TAGs) published by the EMA and the FDA offer guidance in planning the launch of a trial in a certain indication. We assessed and compared the guidance on preclinical efficacy of all available TAGs from EMA and FDA. EMA and FDA websites and databases were searched for all TAGs. A mixed deductive and inductive approach was applied to analyse and cluster content for preclinical efficacy. A total of 114 EMA and 120 FDA TAGs were identified, covering 126 indications. Our core finding is that 75% of EMA TAGs and 58% from the FDA TAGs do not offer any guidance on preclinical efficacy. TAGs varied widely on the extent, nature and detail of guidance. Guidance on preclinical efficacy in a consistent, comprehensive and explicit way that still allows for justified deviations is an important but neglected aspect of transparency for drug development. This transparency would help sponsors in designing preclinical studies and in negotiating more efficiently with regulators.

References

Jan 1, 1994·Journal of Cellular Biochemistry. Supplement·G J KelloffG Burke
Dec 3, 1999·Stroke; a Journal of Cerebral Circulation·UNKNOWN Stroke Therapy Academic Industry Roundtable (STAIR)
Mar 28, 2003·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·H VerhagenS Yannai
Jul 24, 2004·Circulation Research·Roberto BolliUNKNOWN NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Rinaldo BellomoUNKNOWN Acute Dialysis Quality Initiative workgroup
May 17, 2005·Vaccine·Arun T KamathUNKNOWN World Health Organization
Feb 15, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Sean ScottJames A Heywood
Aug 16, 2008·Stroke; a Journal of Cerebral Circulation·Malcolm R MacleodDavid W Howells
Feb 28, 2009·Stroke; a Journal of Cerebral Circulation·Marc FisherUNKNOWN STAIR Group
Apr 1, 2009·Journal of Neurotrauma·Susan MarguliesUNKNOWN Combination Therapies for Traumatic Brain Injury Workshop Leaders
Oct 1, 2008·Circulation. Cardiovascular Interventions·Robert S SchwartzRobert L Wilensky
Feb 27, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Albert C LudolphStephan von Horsten
Jan 1, 2009·Journal of Experimental Stroke & Translational Medicine·Shimin LiuH Richard Winn
Jan 29, 2011·Stroke; a Journal of Cerebral Circulation·Sean I SavitzUNKNOWN STEPS Participants
Jul 9, 2011·Neuromuscular Disorders : NMD·Raffaella WillmannUNKNOWN TREAT-NMD Neuromuscular Network
Sep 6, 2011·Nature Reviews. Drug Discovery·Florian PrinzKhusru Asadullah
Sep 29, 2011·Alzheimer's Research & Therapy·Diana W ShinemanHoward M Fillit
Mar 31, 2012·Nature·C Glenn Begley, Lee M Ellis
Nov 2, 2012·Disease Models & Mechanisms·David M KatzLaura A Mamounas
Oct 19, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Henrik Tang VestergaardCarla Herberts
Nov 20, 2013·Nature Reviews. Neurology·David W HowellsMalcolm R Macleod
Jan 11, 2014·Nature Biotechnology·Michael HayJesse Rosenthal
Mar 22, 2014·Human Gene Therapy. Clinical Development·Gopalan NarayananJean-Hugues Trouvin
May 20, 2015·Clinical and Molecular Allergy : CMA·Carlo AgostiniEnrico Maggi
Feb 6, 2017·Nature·Jonathan Kimmelman, Carole Federico
Apr 14, 2018·Science·Emma Yasinski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved